In contrast, a slower velocity of T cell activation and cytotoxicity might prove beneficial for long-term effector function, as CD28 CARs showed increased exhaustion, reduced tumor elimination, and limited persistence in clinical settings compared to 4-1BB CARs [27,43,44,45,46]. Here, CD28 is linked to neoplasm.